PMID: 25731442Mar 4, 2015Paper

Postoperative cholangitis of balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma

Gan to kagaku ryoho. Cancer & chemotherapy
Kazutoshi OkabeHideo Baba

Abstract

In 35 patients who underwent balloon-occluded transarterial chemoembolization (B-TACE) for hepatocellular carcinoma (HCC) since January 2013, 5 patients (14%) had postoperative cholangitis, 1 of whom required drainage of a liver abscess. Four of these patients(80%)were treated with cisplatin (CDDP)-epirubicin (EPI)-Lipiodol (Lp) emulsion, and 1 was treated with EPI-Lp emulsion.The balloon was located and inflated at the lobar level (C: conventional)in 3 patients (60%) and at the subsegmental or more distal level (SS: superselective) in 2 patients (40%). Chemical vascular damage was considered to cause the cholangitis.We conclude that it is necessary to determine the optimal drug for B-TACE to reduce vascular damage. Miriplatin may be useful because of its lower vascular damage compared with CDDP-Lp and EPI-Lp.

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Hepatology Research : the Official Journal of the Japan Society of Hepatology
Hirotaka AraiKen Sato
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen
U Matzander
Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy
Tomohiro MatsumotoTerumitsu Hasebe
Nihon rinsho. Japanese journal of clinical medicine
T YamasakiK Okita
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Felix FlohrHans C Spangenberg
© 2022 Meta ULC. All rights reserved